Premium
Use of cetuximab as an adjuvant agent to radiotherapy and surgery in recessive dystrophic epidermolysis bullosa with squamous cell carcinoma
Author(s) -
Kim M.,
Li M.,
Intong L.R.A.,
Tran K.,
Melbourne W.,
Marucci D.,
Bucci J.,
de Souza P.,
Mallesara G.,
Murrell D.F.
Publication year - 2013
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/bjd.12272
Subject(s) - medicine , cetuximab , radiation therapy , axilla , dermatology , epidermolysis bullosa , surgery , cancer , oncology , pathology , breast cancer , colorectal cancer